Blood Screening Market | Business Overview | Forecast to 2021
Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital)
(firmenpresse) - The global blood screening market is expected to reach $2.80 billion by 2021 from $1.76 billion in 2016, at a CAGR of 9.7%
Download FREE Brochure (at)
The major players in the blood screening market are Grifols (Spain), Bio-Rad Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), bioM
Major Market Development:
-In June 2016, Grifols and Hologic, Inc. (U.S.) announced the U.S. FDA approval of the Procleix Zika virus blood-screening assay on the Procleix Panther system under the agency''s Investigational New Drug (IND) study protocol. This enhanced the company
-In October 2016, Roche announced the FDA approval of the cobas MPX test for use on the cobas 6800 and 8800 Systems. This detects HIV-1, HIV-2, HBV, and HCV in transfused blood products.
-In July 2015, Roche announced the market availability of the Elecsys HTLV-I/II immunoassay. This diagnostic test detects antibodies against Human T-lymphotropic virus I & II infections in donated blood and routine diagnostic samples.
The global blood screening market is broadly classified into technology, product & service, end user, and region. The ELISA segment is projected to register the highest CAGR during the forecast period. The increasing number of donations, its low cost, growing prevalence/incidence of infectious diseases, and the increasing demand for donated blood are the major factors contributing to the growth of the ELISA market.
Moreover, the high cost of NAT testing makes it unaffordable for developing economies, leaving them to rely on ELISA testing for blood screening.
Request for Sample (at)
List of Figures (39 Figures)
Figure 1 Research Design
Figure 2 Blood Screening Market: Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Blood Screening Market Size, By Product and Service, 2016 vs 2021 (USD Billion)
Figure 6 Blood Screening Market Size, By Technology, 2016 vs 2021 (USD Billion)
Figure 7 Blood Screening Market Size, By End User, 2016 vs 2021 (USD Billion)
Figure 8 North America Accounted for the Highest Share of the Blood Screening Market in 2016
Figure 9 Blood Screening Market to Showcase Lucrative Growth Opportunities in the Forecast Period
Figure 10 NAT Segment to Account for the Largest Market Share in 2016
About MarketsandMarkets
MarketsandMarkets
Our 850 fulltime analyst and SMEs at MarketsandMarkets"Growth Engagement Model ". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets"Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 25.04.2019 - 03:24 Uhr
Sprache: Deutsch
News-ID 1548756
Anzahl Zeichen: 4894
contact information:
Contact person: Mr Shelly Singh
Town:
Northbrook
Phone: 8886006441
Kategorie:
Medical Devices
Typ of Press Release: Financial
type of sending: send
Date of sending: 25.04.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 620 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Blood Screening Market | Business Overview | Forecast to 2021
"
steht unter der journalistisch-redaktionellen Verantwortung von
MarketsandMarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
